Scarica l'app Stockscreener
1.82
2.15%
-0.04
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PYXS Giù?
Forum
Previsione
Precedente Chiudi:
$1.86
Aprire:
$1.84
Volume 24 ore:
723.15K
Relative Volume:
1.19
Capitalizzazione di mercato:
$112.87M
Reddito:
-
Utile/perdita netta:
$-73.79M
Rapporto P/E:
-0.9891
EPS:
-1.84
Flusso di cassa netto:
$-77.44M
1 W Prestazione:
-4.71%
1M Prestazione:
+75.00%
6M Prestazione:
+63.96%
1 anno Prestazione:
-50.00%
Intervallo 1D:
$1.76
$1.92
Intervallo di 1 settimana:
$1.75
$2.00
Portata 52W:
$0.8332
$5.3899
Pyxis Oncology Inc Stock (PYXS) Company Profile
Nome
Pyxis Oncology Inc
Settore
Industria
Telefono
(617) 221-9059
Indirizzo
321 HARRISON AVENUE, BOSTON
Confronta PYXS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PYXS
Pyxis Oncology Inc
|
1.82 | 115.97M | 0 | -73.79M | -77.44M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Pyxis Oncology Inc Stock (PYXS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-04 | Iniziato | Guggenheim | Buy |
| 2024-11-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-11-08 | Iniziato | Stephens | Overweight |
| 2024-08-08 | Iniziato | Stifel | Buy |
| 2024-05-07 | Ripresa | Jefferies | Buy |
| 2024-02-09 | Iniziato | BTIG Research | Buy |
| 2024-01-23 | Iniziato | Leerink Partners | Outperform |
| 2023-09-05 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-11-02 | Iniziato | BofA Securities | Neutral |
| 2021-11-02 | Iniziato | Credit Suisse | Outperform |
| 2021-11-02 | Iniziato | Jefferies | Buy |
Mostra tutto
Pyxis Oncology Inc Borsa (PYXS) Ultime notizie
How hedge fund analytics apply to Pyxis Oncology Inc. stockPortfolio Growth Summary & Momentum Based Trading Signals - Newser
Pyxis Oncology Inc. stock trend forecast2025 Price Momentum & Daily Market Momentum Tracking - Newser
News impact scoring models applied to Pyxis Oncology Inc.Market Rally & Reliable Breakout Forecasts - Newser
Technical analysis overview for Pyxis Oncology Inc. stockRate Cut & Low Risk Investment Opportunities - Newser
Analyzing Pyxis Oncology Inc. with multi timeframe chartsFed Meeting & Real-Time Buy Signal Alerts - Newser
Does Pyxis Oncology Inc. fit your quant trading modelWeekly Trade Recap & Fast Entry High Yield Tips - Newser
What recovery options are there for Pyxis Oncology Inc.Oil Prices & Capital Protection Trade Alerts - Newser
Detecting price anomalies in Pyxis Oncology Inc. with AIBuy Signal & Accurate Entry and Exit Point Alerts - Newser
Order flow analysis tools used on Pyxis Oncology Inc.July 2025 Sentiment & Entry Point Confirmation Alerts - Newser
Real time social sentiment graph for Pyxis Oncology Inc.2025 Technical Patterns & Fast Entry High Yield Tips - Newser
Published on: 2025-09-12 17:12:16 - Newser
Applying big data sentiment scoring on Pyxis Oncology Inc.Stock Surge & Breakout Confirmation Trade Signals - Newser
Tools to assess Pyxis Oncology Inc.’s risk profile2025 AllTime Highs & Daily Volume Surge Trade Alerts - Newser
Analyzing recovery setups for Pyxis Oncology Inc. investorsQuarterly Earnings Summary & Short-Term High Return Strategies - Newser
Does Pyxis Oncology Inc. show high probability of reboundJuly 2025 PreEarnings & Consistent Profit Trading Strategies - Newser
American Century Companies Inc. Sells 273,584 Shares of Pyxis Oncology, Inc. $PYXS - MarketBeat
Pyxis Oncology: Readouts Ahead, Although Cash Might Dwindle (Rating Downgrade) (NASDAQ:PYXS) - Seeking Alpha
Is Pyxis Oncology Inc. building a consolidation baseEarnings Miss & Community Driven Trade Alerts - Newser
How to recover losses in Pyxis Oncology Inc. stockJuly 2025 News Drivers & Risk Managed Investment Strategies - Newser
Is Pyxis Oncology Inc. still worth holding after the dipJuly 2025 Volume & Growth Focused Stock Reports - Newser
Is Pyxis Oncology Inc. stock entering bullish territory2025 Support & Resistance & Safe Entry Trade Signal Reports - Newser
Pyxis Oncology (NASDAQ:PYXS) Earns Buy Rating from Analysts at Guggenheim - MarketBeat
Best data tools to analyze Pyxis Oncology Inc. stock2025 Buyback Activity & Fast Gain Stock Trading Tips - Newser
What institutional flow reveals about Pyxis Oncology Inc.July 2025 Fed Impact & Verified Momentum Watchlists - Newser
Using RSI to spot recovery in Pyxis Oncology Inc.2025 Price Action Summary & Free Real-Time Volume Trigger Notifications - Newser
Real time scanner hits for Pyxis Oncology Inc. explainedTrade Entry Summary & Precise Buy Zone Identification - Newser
Is now a turning point for Pyxis Oncology Inc.Rate Hike & Daily Stock Trend Reports - Newser
Is it too late to sell Pyxis Oncology Inc.Weekly Profit Analysis & Consistent Growth Equity Picks - Newser
Short interest data insights for Pyxis Oncology Inc.Dip Buying & Free Reliable Trade Execution Plans - Newser
Will Pyxis Oncology Inc. benefit from macro trendsJuly 2025 Drop Watch & AI Optimized Trading Strategy Guides - Newser
How to use Fibonacci retracement on Pyxis Oncology Inc.July 2025 Reactions & Consistent Return Strategy Ideas - Newser
Can technical indicators confirm Pyxis Oncology Inc.’s reversalVolume Spike & Long-Term Safe Investment Plans - Newser
Pyxis Oncology Inc. stock prediction for this weekMarket Trend Report & Verified High Yield Trade Plans - Newser
Custom strategy builders for tracking Pyxis Oncology Inc.2025 Investor Takeaways & Short-Term Trading Alerts - Newser
Pyxis Oncology Inc Azioni (PYXS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):